Fibulin-3 Deficiency Protects Against Myocardial Injury Following Ischaemia/ Reperfusion in
Fibulin-3 KO
I/R injury
cardiac spheroids
in vitro cardiac models
myocardial infarction
reperfusion injury
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
04
2022
accepted:
30
05
2022
entrez:
7
7
2022
pubmed:
8
7
2022
medline:
8
7
2022
Statut:
epublish
Résumé
Myocardial infarction (MI, or heart attack) is a leading cause of death worldwide. Myocardial ischaemia reperfusion (I/R) injury typical of MI events is also associated with the development of cardiac fibrosis and heart failure in patients. Fibulin-3 is an extracellular matrix component that plays a role in regulating MI response in the heart. In this study, we generated and compared
Identifiants
pubmed: 35795376
doi: 10.3389/fcvm.2022.913156
pmc: PMC9251181
doi:
Types de publication
Journal Article
Langues
eng
Pagination
913156Informations de copyright
Copyright © 2022 Sharma, Beck, Murtha, Figtree, Boyle and Gentile.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Genet. 2019 Jan;51(1):51-62
pubmed: 30578418
Biofabrication. 2022 Jan 24;14(2):
pubmed: 34983029
Exp Eye Res. 2010 Mar;90(3):374-5
pubmed: 19799900
Int Rev Cell Mol Biol. 2020;354:261-353
pubmed: 32475476
Microvasc Res. 2020 Nov;132:104043
pubmed: 32707048
Cell Physiol Biochem. 2018;46(4):1305-1316
pubmed: 29689558
Front Cell Dev Biol. 2021 Mar 04;9:639952
pubmed: 33748129
Clin Exp Dermatol. 2019 Jun;44(4):e64-e72
pubmed: 30146751
Sci Rep. 2018 Jul 13;8(1):10594
pubmed: 30006571
Biofabrication. 2021 Aug 13;13(4):
pubmed: 34265755
Cartilage. 2019 Jul;10(3):329-334
pubmed: 29366335
Mol Med Rep. 2016 May;13(5):3805-12
pubmed: 27035767
Hum Mol Genet. 2007 Dec 15;16(24):3059-70
pubmed: 17872905
Cancer Res. 2014 Oct 1;74(19):5435-5448
pubmed: 25139440
Carcinogenesis. 2014 Aug;35(8):1707-16
pubmed: 24480807
Bio Protoc. 2018 Sep 05;8(17):e2995
pubmed: 34395793
Sci Rep. 2017 Aug 1;7(1):7005
pubmed: 28765558
Arthritis Rheumatol. 2017 Mar;69(3):576-585
pubmed: 27780308
J Biol Chem. 2007 Apr 20;282(16):11805-16
pubmed: 17324935
J Invest Dermatol. 2019 Aug;139(8):1798-1808.e5
pubmed: 30738056
Small. 2021 Apr;17(15):e2003765
pubmed: 33464713
Matrix Biol. 1999 Oct;18(5):469-80
pubmed: 10601734
Nat Rev Cardiol. 2020 Dec;17(12):773-789
pubmed: 32620851
Biomolecules. 2020 Sep 08;10(9):
pubmed: 32911658
Oncogene. 2017 Aug 24;36(34):4875-4886
pubmed: 28414309
Circ Genom Precis Med. 2019 Aug;12(8):e002491
pubmed: 31430208
Onco Targets Ther. 2020 Oct 15;13:10535-10546
pubmed: 33116632
J Clin Invest. 2018 Nov 1;128(11):5018-5033
pubmed: 30295643
J Vis Exp. 2016 Aug 14;(114):
pubmed: 27585062
PLoS One. 2014 Aug 12;9(8):e104157
pubmed: 25117565
Biol Chem. 2009 Dec;390(12):1293-302
pubmed: 19804359
Sci Transl Med. 2013 May 1;5(183):183ra58, 1-11
pubmed: 23636094
Cardiovasc Res. 2021 Apr 23;117(5):1257-1273
pubmed: 33063086
Mol Cell Biol. 1995 Jan;15(1):120-8
pubmed: 7799918
Sci Rep. 2017 Apr 04;7:45652
pubmed: 28374850
Int J Mol Sci. 2018 Sep 17;19(9):
pubmed: 30227601
Apoptosis. 2014 Aug;19(8):1254-68
pubmed: 24893993
EMBO Rep. 2003 Dec;4(12):1127-31
pubmed: 14647206
Cancer Res. 2006 Mar 1;66(5):2621-9
pubmed: 16510581